Journal article · 2024 · Open access

Gut Microbiome’s Next Generation Probiotic: Akkermansia Overview and Supplementation Health Benefits

Subhendu Nayak, Meghan E. McLean, Swetaleena Mishra, Ranjan Kumar Sahoo, Durga Madhab Swain

Acta Scientifci Nutritional Health, 20–28 · Published 1 June 2024 · DOI 10.31080/asnh.2024.08.1382

Open PDFView at the publisherCite this paper

In brief

“Gut Microbiome’s Next Generation Probiotic: Akkermansia Overview and Supplementation Health Benefits” is a 2024 journal article by Subhendu Nayak and 4 co-authors, published in Acta Scientifci Nutritional Health. OpenAlex counts 1 citations as of 18 November 2026. It is open access: the full text is free to read at Acta Scientifci Nutritional Health.

Citations
1
Most cited in
2024 (1)
Field-weighted impact
0.10
References
67
Authors
5

Abstract

A bacterium known as Akkermansia muciniphila (AkkermansiaA.muciniphila) was detected in human feces in 2004.It is defined as a gram-negative, anaerobic, and mucin-degrading microbe belonging to the Verrucomicrobia species.Although the majority of A. muciniphila is found in the human intestinal tract playing a role in the gut microbiome, there are also smaller levels detected in breast milk and oral cavities as well as in the pancreas and appendix.Evidence suggests that having A. muciniphila present in the gut microbiome has positive effects on human health.As a result, A. muciniphila has been shown to have health benefits when taken as a dietary supplementation where it is considered a promising next-generation probiotic.However, the large-scale production of A. muciniphila remains a challenge due to its need for a stable environment.While culturing A. muciniphila in a mucin-based medium is one option, other strategies that use plate-based mediums have also been explored.Currently, both live and pasteurized forms of A. muciniphila are available on the market and shown to have promising outcomes in animal models.Additionally, researchers are investigating various prebiotics to increase the abundance of A. muciniphila in the human gut.This article presents a detailed summary of the phenotypic characteristics of A. muciniphila and its associations with various human health condition illnesses.Finally, the paper explores A. muciniphila's potential as an effective next-generation probiotic.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Nayak, S., McLean, M. E., Mishra, S., Sahoo, R. K., & Swain, D. M. (2024). Gut Microbiome’s Next Generation Probiotic: Akkermansia Overview and Supplementation Health Benefits. Acta Scientifci Nutritional Health, 20–28. https://doi.org/10.31080/asnh.2024.08.1382

MLA 9

Nayak, Subhendu, et al. “Gut Microbiome’s Next Generation Probiotic: Akkermansia Overview and Supplementation Health Benefits.” Acta Scientifci Nutritional Health, 2024, pp. 20–28. https://doi.org/10.31080/asnh.2024.08.1382.

Chicago

Nayak, Subhendu, Meghan E. McLean, Swetaleena Mishra, Ranjan Kumar Sahoo, and Durga Madhab Swain. 2024. “Gut Microbiome’s Next Generation Probiotic: Akkermansia Overview and Supplementation Health Benefits.” Acta Scientifci Nutritional Health: 20–28. https://doi.org/10.31080/asnh.2024.08.1382.

Harvard

Nayak, S. et al. (2024) ‘Gut Microbiome’s Next Generation Probiotic: Akkermansia Overview and Supplementation Health Benefits’, Acta Scientifci Nutritional Health, pp. 20–28. doi:10.31080/asnh.2024.08.1382.

IEEE

S. Nayak, M. E. McLean, S. Mishra, R. K. Sahoo, and D. M. Swain, “Gut Microbiome’s Next Generation Probiotic: Akkermansia Overview and Supplementation Health Benefits,” Acta Scientifci Nutritional Health, pp. 20–28, 2024, doi: 10.31080/asnh.2024.08.1382.

BibTeX

@article{nayak2024microbiome,
  title     = {{Gut Microbiome’s Next Generation Probiotic: Akkermansia Overview and Supplementation Health Benefits}},
  author    = {Nayak, Subhendu and McLean, Meghan E. and Mishra, Swetaleena and Sahoo, Ranjan Kumar and Swain, Durga Madhab},
  journal   = {Acta Scientifci Nutritional Health},
  year      = {2024},
  pages     = {20--28},
  doi       = {10.31080/asnh.2024.08.1382},
  url       = {https://doi.org/10.31080/asnh.2024.08.1382}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health

  • Akkermansia muciniphila
  • gut microbiota
  • probiotics
  • prebiotics
  • mucin degradation
  • Verrucomicrobia
  • dietary supplementation
  • probiotic production

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Nayak, S., McLean, M. E., Mishra, S., Sahoo, R. K., & Swain, D. M. (2024). Gut Microbiome’s Next Generation Probiotic: Akkermansia Overview and Supplementation Health Benefits. Acta Scientifci Nutritional Health, 20–28. https://doi.org/10.31080/asnh.2024.08.1382

How many times has this paper been cited?

1 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Acta Scientifci Nutritional Health: sign in and open the PDF from this page.

Who wrote this paper?

Subhendu Nayak, Meghan E. McLean, Swetaleena Mishra, Ranjan Kumar Sahoo, Durga Madhab Swain.

What is the DOI of this paper?

10.31080/asnh.2024.08.1382, permanently at https://doi.org/10.31080/asnh.2024.08.1382. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.